Praetorian Bio develops oral vaccines aimed at preventing gum disease and reducing associated systemic health risks.
Praetorian Bio has raised $1.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2026.
Praetorian Bio's investors include Plug and Play.
Praetorian Bio is headquartered in Potomac, United States.
Praetorian Bio develops oral vaccines aimed at preventing gum disease and reducing associated systemic health risks.
Praetorian Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Praetorian Bio — Funding & Investors." VCBacked, October 26, 2026, https://www.vcbacked.co/company/praetorian-bio. Accessed November 2, 2026.
VCBacked. (2026). Praetorian Bio — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/praetorian-bio
{{cite web |title=Praetorian Bio — Funding & Investors |url=https://www.vcbacked.co/company/praetorian-bio |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Praetorian Bio? Request a listing update